FDA Approved: BRIVIACT — Original Application (UCB, Inc.)

View source ↗

Summary

FDA approved Briviact (brivaracetam) under its original application by UCB, Inc. for adjunctive treatment of partial-onset seizures in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Briviact (brivaracetam)

Snippet

ORIG AP for BRIVIACT (BRIVARACETAM)